A new approach for implantation of a cardiac resynchronization therapy–defibrillator in a patient with bilateral pectoral neurostimulation devices

Ítems similars

• Current status of cardiac resynchronization therapy with defibrillators and factors influencing its prognosis in Japan
  per: Akihiko Shimizu, et al.
  Publicat: (2013-06-01)
• A Low Critical Event Rate Despite a High Abnormal Event Rate in Patients with Cardiac Implantable Electric Devices Followed Up by Remote Monitoring
  per: Morimoto, Yoshimasa, et al.
  Publicat: (2019)
• Trends and determinant factors in the use of cardiac resynchronization therapy devices in Japan: Analysis of the Japan cardiac device treatment registry database
  per: Yokoshiki, Hisashi, et al.
  Publicat: (2016)
• A novel use of cardiac resynchronization therapy‐defibrillator device in hypertrophic cardiomyopathy
  per: Cay, Serkan, et al.
  Publicat: (2018)
• Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
  per: Sugiyama, Hirotaro, et al.
  Publicat: (2017)